2023 and TAVR - Cardiovascular Update

New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance

DAIC

JUNE 7, 2024

milla1cf Fri, 06/07/2024 - 14:50 June 7, 2024 — Medtronic today announced new data from the CoreValve Evolut Clinical Program , reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve replacement (SAVR) and other TAVR valves. Evolut vs. 10.6%

TAVR

TAVR Aortic valve Aortic Stenosis

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

APRIL 30, 2024

Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5% SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. in 2023, of which 60% included double valve replacements, and 25% involved concomitant CABG.

TAVR

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft

Redo-TAVR with balloon-expandable valves: outcomes from a national registry

Cardiology Update

NOVEMBER 26, 2023

In light of the growing number of patients undergoing transcatheter aortic valve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. vs. 3.5%, p=0.80) between the redo-TAVR and native-TAVR populations.

TAVR

TAVR Aortic valve Outcomes Aortic

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

JANUARY 29, 2024

Cardiac Surgery after Transcatheter Aortic Valve Replacement: Trends and Outcomes The researchers set out to document trends and outcomes in cardiac surgery following transcatheter aortic valve replacement (TAVR), a topic gaining importance as reports of subsequent cardiac operations and early TAVR explantations increase.

Research

Research TAVR Aortic valve Atrial Fibrillation

Teleflex Announces the Limited Market Release of the Wattson Temporary Pacing Guidewire

DAIC

MAY 6, 2024

Featuring a simple design to create procedural efficiencies, the Wattson Temporary Pacing Guidewire offers dual functionality, supporting both valve delivery and ventricular bipolar pacing during structural heart procedures, including transcatheter aortic valve replacement (TAVR) and balloon aortic valvuloplasty (BAV).

TAVR

TAVR Aortic valve Aortic Technology

ABMS Rejects Independent CV Board, Doesn’t Explain Why

CardiacWire

MARCH 5, 2025

Pushing for independence since 2023, the new American Board of Cardiovascular Medicine would have been completely independent of the ABIM and focused solely on the certification processes for U.S. When ABIM started offering cardiology boards in 1941, electrophysiology, TAVR, and many other complex procedures didnt exist.

Certification

Certification TAVR Electrophysiology

2023 STS Coding Workshop

Society of Thoracic Surgeons - Allied Health

NOVEMBER 15, 2022

Event 2023 STS Coding Workshop kchalko Tue, 11/15/2022 - 16:12 Event dates Feb 10–11, 2023 Location Virtual Registrants : To access the library of on-demand content, log into the STS Learning Center. Then go to “In Progress” courses on the dashboard or look in the “My Activities” tab. Missed the event? STS Members receive a discount!

Reimbursement

Reimbursement Cardiothoracic Document Congenital

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013238, November 1, 2023. BACKGROUND:Coronary accessibility following redo–transcatheter aortic valve replacement (redo-TAVR) is increasingly important, particularly in younger low-risk patients. Two initial Evolut implant depths were analyzed, 3 and 5 mm.

TAVR

TAVR Aortic valve Anatomy Cardiovascular Interventions

MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

DAIC

DECEMBER 26, 2023

milla1cf Tue, 12/26/2023 - 21:36 December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new technology - In-ear Infrasonic Hemodynography to Detects Aortic Stenosis Murmur Before and After Transcatheter Aortic Valve Replacement (TAVR). the R&D Manager of MindMics.

Stenosis

Stenosis Technology Aortic Aortic valve

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

DAIC

FEBRUARY 15, 2024

Abbott submitted its pre-market approval (PMA) application for the TriClip device in March 2023 to the FDA, which lead to today's advisory committee panel for expert advice on the device's clinical safety, effectiveness, risk and benefit. The FDA routinely seeks input from advisory committees, especially for first-of-a-kind medical devices.

Tricuspid

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral

Incorporating Redo-TAVR Feasibility Into Lifelong Aortic Valve Management

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013571, November 1, 2023.

Aortic valve

Aortic valve TAVR Cardiovascular Interventions Aortic

CT Simulation for Redo-TAVR: Can We Predict Future Coronary Access?

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e013572, November 1, 2023.

TAVR

TAVR Cardiovascular Interventions Circulation

Abstract 4142104: Ischemic Stroke and TIA Incidence in Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement: A Comparative Systematic Review and Meta-analysis

Circulation

NOVEMBER 11, 2024

Seven studies showed that TAVR patients had a similar 1-year stroke risk to SAVR patients (OR 0.92, 95% CI 0.64 In the TIA case, there was no evidence of a significant difference between TAVR and SAVR in the risk of having a transient ischemic attack within 30 days following surgery (OR 0.93, 95% CI 0.24 to 1.17, p=0.30, I2 3%).

Aortic valve

Aortic valve Aortic TAVR Strokes

Non-dual antiplatelet therapy versus dual antiplatelet therapy prior to transcatheter aortic valve replacement: A systematic review and meta-analysis

Journal of Cardiovascular Pharmacology

NOVEMBER 21, 2023

Abstract: Transcatheter aortic valve replacement (TAVR) is an interventional procedure performed in patients with severe aortic stenosis and often required perioperative antiplatelet therapy. Most previous studies have focused on antiplatelet therapy following TAVR. Copyright © 2023 Wolters Kluwer Health, Inc.

Aortic valve

Aortic valve Aortic TAVR Myocardial Infarction

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Circulation: Cardiovascular Interventions, Volume 16, Issue 11 , Page e012966, November 1, 2023. Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients.

Aortic valve

Aortic valve Aortic TAVR Heart Valves

Navigating the Uncertainty: A New Score to Guide TAVR in Patients With Chronic Kidney Disease

The American Journal of Cardiology

DECEMBER 13, 2023

Publication date: Available online 18 November 2023 Source: The American Journal of Cardiology Author(s): Anish K. Desai, Yaqub Betz, Antonio Abbate

Kidney Disease

Kidney Disease TAVR

New Study Shows Excellent Long-term Survival After SAVR

Society of Thoracic Surgeons - Congenital

OCTOBER 17, 2023

Press Release New Study Shows Excellent Long-term Survival After SAVR October 17, 2023 KCummings Tue, 10/17/2023 - 12:02 Using Largest U.S. The study matched the criterion used in the current low-risk trials evaluating SAVR with transcatheter aortic valve replacement (TAVR). Overall, 92.9% The average age of patients was 74.2

Aortic valve

Aortic valve TAVR Aortic Cardiothoracic

Cardiology AI Clearances Growing, Diversifying

CardiacWire

AUGUST 9, 2024

Overall healthcare AI clearances seem to be stable, with the first half of 2024 bringing 107 total clearances, which is just behind pace of 2023’s full year total (220).

Innovation

Innovation TAVR Cardiovascular Imaging Plaque

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve

Aortic valve Myocardial Infarction Aortic Blood Pressure

American College of Cardiology (ACC24) Show Preview: Advancing Cardiovascular Care for All

DAIC

MARCH 25, 2024

BE ACTIVE—about physical activity and how physical activity is enhanced in patients looking at financial incentivization as well as gamification, and what that does for physical activity with regards to patients who have MI and a high risk for cardiovascular disease.

Education

Education Cardiogenic Shock Heart Failure Plaque

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

Published Research

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Published Research kschukar Thu, 04/20/2023 - 11:12 Recently published (2016 – present) manuscripts utilizing STS data: Adult Cardiac Surgery, General Thoracic Surgery, Congenital Heart Surgery, and Intermacs/Pedimacs.

Research

Research Coronary Artery Bypass Graft Aortic valve Congenital

New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

Redo-TAVR with balloon-expandable valves: outcomes from a national registry

Webinars

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

Teleflex Announces the Limited Market Release of the Wattson Temporary Pacing Guidewire

ABMS Rejects Independent CV Board, Doesn’t Explain Why

2023 STS Coding Workshop

Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study

MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

FDA Advisory Committee Votes in Favor of Abbott’s First-of-its-kind Triclip System to Treat People with a Leaky Tricuspid Heart Valve

Incorporating Redo-TAVR Feasibility Into Lifelong Aortic Valve Management

CT Simulation for Redo-TAVR: Can We Predict Future Coronary Access?

Abstract 4142104: Ischemic Stroke and TIA Incidence in Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement: A Comparative Systematic Review and Meta-analysis

Non-dual antiplatelet therapy versus dual antiplatelet therapy prior to transcatheter aortic valve replacement: A systematic review and meta-analysis

Challenges and Future Directions in Redo Aortic Valve Reintervention After Transcatheter Aortic Valve Replacement Failure

Navigating the Uncertainty: A New Score to Guide TAVR in Patients With Chronic Kidney Disease

New Study Shows Excellent Long-term Survival After SAVR

Cardiology AI Clearances Growing, Diversifying

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

American College of Cardiology (ACC24) Show Preview: Advancing Cardiovascular Care for All

Published Research

Published Research

Stay Connected